Furthermore, osteoblast-derived growth differentiation factor 10 (GDF10) and TGF-β2 have been reported to induce prostate cancer cell dormancy via activation of TGFBR3–p38 MAPK signaling [98]. Here, TGFB2 is linked to prostate carcinoma.